Novavax Inc
NVAXNasdaqCIK 1000694HealthcareFiscal year ends Dec 31
Reports and events: 382 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2916:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-120221 |
| 2026-10-1616:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001398344-26-018323 |
| 2026-08-0608:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001000694-26-000019 |
| 2026-08-0607:50 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001000694-26-000018 |
| 2026-06-2308:00 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-076648 |
| 2026-05-1508:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001398344-26-009210 |
| 2026-05-0608:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-030924 |
| 2026-05-0607:50 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-030917 |
| 2026-04-2708:00 ET | DEF 14A | Proxy statementPeriod 2026-06-18 | 0001628280-26-027328 |
| 2026-04-0806:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001398344-26-006235 |
| 2026-02-2608:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001000694-26-000011 |
| 2026-02-2607:33 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001000694-26-000007 |
| 2026-01-2006:59 ET | 8-K | 1.01 Entry into a material agreement | 0001104659-26-004785 |
| 2026-01-1208:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-002725 |
| 2025-11-1216:17 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001398344-25-020786 |
| 2025-11-0608:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001000694-25-000048 |
| 2025-11-0607:47 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001000694-25-000046 |
| 2025-11-0406:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-105818 |
| 2025-10-2207:00 ET | 8-K | 1.01 Entry into a material agreement; 2.06 Material impairments; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-101390 |
| 2025-10-1407:45 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001398344-25-019099 |
| 2025-10-0707:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-097317 |
| 2025-08-2716:40 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-25-084053 |
| 2025-08-2716:38 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-084049 |
| 2025-08-2107:48 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-081160 |
| 2025-08-0608:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001000694-25-000031 |
| 2025-08-0607:47 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001000694-25-000029 |
| 2025-06-2406:03 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-061874 |
| 2025-06-1107:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-058379 |
| 2025-05-2716:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-052959 |
| 2025-05-1907:34 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events | 0001104659-25-050226 |
| 2025-05-0808:26 ET | 8-K | 2.02 Results of operations | 0001000694-25-000024 |
| 2025-05-0807:59 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001000694-25-000021 |
| 2025-05-0509:25 ET | 8-K | 1.01 Entry into a material agreement | 0001104659-25-044372 |
| 2025-04-2908:51 ET | DEF 14A | Proxy statementPeriod 2025-06-20 | 0001000694-25-000013 |
| 2025-04-2908:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-040656 |
| 2025-04-2308:00 ET | 8-K | 7.01 Regulation FD disclosure | 0001104659-25-037728 |
| 2025-04-0214:52 ET | 8-K | 7.01 Regulation FD disclosure | 0001104659-25-031099 |
| 2025-03-1116:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-022588 |
| 2025-03-1108:30 ET | 8-K | 1.02 Termination of a material agreement | 0001104659-25-022435 |
| 2025-03-0408:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-020023 |
| 2025-02-2708:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001000694-25-000006 |
| 2025-02-2707:41 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001000694-25-000004 |
| 2025-01-1307:50 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-002863 |
| 2024-12-3017:27 ET | 8-K | 2.01 Completion of an acquisition or disposition | 0001104659-24-132569 |
| 2024-12-1817:24 ET | 8-K | 1.01 Entry into a material agreement | 0001104659-24-129823 |
| 2024-12-0406:00 ET | 8-K | 1.01 Entry into a material agreement | 0001104659-24-125265 |
| 2024-11-2020:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-120698 |
| 2024-11-1216:08 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001000694-24-000043 |
| 2024-11-1211:21 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-116593 |
| 2024-11-1208:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001000694-24-000040 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:32 ET. Listed shows no prices and gives no investment advice.